| 摘要: |
| ［摘要］ 目的 分析经直肠超声引导下6+X点前列腺穿刺活检术的操作技巧及临床应用价值。方法 超声引导下对292例患者行前列腺穿刺活检术，统计术后并发症。292例患者中，前列腺癌122例，前列腺良性增生106例，增生并慢性前列腺炎症28例，前列腺增生伴上皮内肿瘤18例，前列腺不典型增生15例，前列腺结核2例,非特异性肉芽肿性前列腺炎1例。结果 采用6+X点穿刺活检术，前列腺癌阳性率为41.78%,平均穿刺针数6+1.73。术后并发症：血尿43例，血便25例，发热20例，少量出血20例，腰痛16例，尿痛14例，排尿不畅11例,大出血1例。结论 经直肠超声引导下6+X点前列腺穿刺活检术操作方便，时间短暂，并发症少，前列腺癌检出率高，有助于早期前列腺癌的诊断及鉴别诊断。 |
| 关键词: 经直肠超声 前列腺穿刺活检术 前列腺癌 |
| DOI：10.3969/j.issn.1674-3806.2014.05.05 |
| 分类号:R 737.25 |
| 基金项目:广西自然科学基金资助项目（编号：2011GXNSFA018295） |
|
| Clinical application of transrectal ultrasound-guided prostate biopsy by 6+X points method: analysis of 292 cases |
|
LIN Yun, WANG Xiao-yan, SHEN Gui-xin, et al.
|
|
Department of Ultrasonography, the People′s Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021,China
|
| Abstract: |
| ［Abstract］ Objective To evaluate the clinical value and operative skills of transrectal ultrasound guided prostate biopsy by 6+X points method.Methods Two hundred and ninety-two patients with histopathologic results underwent prostate biopsy guided by transrectal ultrasound and the postoperative complications were recorded.In 292 patients, prostate cancer were detected in 122 cases, benign prostate hyperplasia in 106 cases, chronic prostatitis in 28 cases, prostatic intraepithelial neoplasia in 18 cases, atypical hyperplasia in 15 cases,prostate tuberculosis in 2 cases, nonspecific granulomatous prostatitis in one case.Results The detection rate of prostate cancer was 41.78%,the average puncture number was (6+1.73)times.After biopsy, the complications included:hematuria in 43 cases， bloody stool in 25 cases,fever in 20 cases，little hemorrhage in 20 cases, pain of back in 16 cases,urodynia in 14 cases,severe massive hemorrhage in one case.Conclusion Transrectal ultrasound-guided prostate biopsy by 6+X points method has advantages of simple operation,less time consuming,less complications and high detection rate and has helpful for the early diagnosis and differential diagnosis of prostate cancer. |
| Key words: Transrectal ultrasound Prostate biopsy Prostatic cancer |
